This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells
The Portuguese company CellmAbs is developing cancer immunotherapies that prevent tumor cells from evading the…
31/01/2020 - 3 minutes
Solid tumors
Merck Spinout Bags €15M Series A to Tackle Cancer and Fibrosis
iOnctura, a spinout from Merck KGaA, has raised €15M to take its cancer and fibrosis…
23/01/2020 - 2 minutes
A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
10/09/2019 - 9 minutes
Why Orthotopic Tumor Models Are Key to Successful Cancer Therapies
One of the greatest challenges faced by researchers in preclinical oncology studies is the translatability…
08/07/2019 - 7 minutes
UK Biotech Gets Huge Grant to Launch Off-the-Shelf CAR-T Cancer Therapy to Clinic
The UK biotech Cell Medica has received a €7.6M ($8.7M) grant from the Cancer Prevention…
27/02/2019 - 3 minutes
CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead
CAR-T cell therapy has been able to effectively treat cancer in some patients for whom…
13/06/2018 - 5 minutes
British Partnership Starts Trial with DNA Cancer Vaccine in Lung Cancer
Scancell and Cancer Research UK team up to run a first clinical trial for a…
14/12/2017 - 2 minutes
Update: French Red Blood Cell Biotech Enters Nasdaq with a $144M IPO
Update (15/11/2017): Erytech has closed its Nasdaq IPO raising a total of $144M (€122M) despite…
15/11/2017 - 2 minutes
German Pharma Enters the Clinic with Solid Tumor Treatment
A Phase I study will investigate the safety and tolerability of Immatics approach to treating…
28/09/2017 - 2 minutes
German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers
Immatics will start a first clinical trial to test IMA101, a personalized cell therapy with…
21/08/2017 - 3 minutes
Swedish Biotech publishes Long-Term Data on a Dendritic Cell Therapy for Cancer
Immunicum has reported new data on long-term follow-up of patients treated with ilixadencel, a unique…
20/06/2017 - 3 minutes
Celyad Reports Impressive Preliminary CAR-T Results in Solid Tumors
Celyad has announced no toxicity and stable disease in colorectal cancer patients after just 3…
19/06/2017 - 2 minutes
